Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Intarcia Therapeutics presents ITCA-50 clinical results

May 9, 2016

New joint venture formed to focus on obtaining Chinese approval for Dance-501

May 9, 2016

Dimension Therapeutics and PENN enter inherited metabolic disease collaboration

May 9, 2016

Novo Nordisk reports GLP-1 analogues

May 6, 2016

Kastle Therapeutics acquires global development and commercialization rights for Kynamro

May 5, 2016

EMA grants accelerated assessment to cerliponase alfa MAA

May 4, 2016

Kamada receives two milestone payments from AAT agreements

May 3, 2016

Novel genetic variant may cause mitochondrial diseases

April 29, 2016

Sanofi enters collaborations to predict diabetes medication adherence

April 28, 2016

Positive results from phase II study of AZP-531 in Prader-Willi Syndrome

April 28, 2016

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...